Cytomegalovirus DNAemia in patients with de novo acute myeloid leukemia undergoing cytotoxic chemotherapy

Leuk Lymphoma. 2019 Dec;60(12):3081-3083. doi: 10.1080/10428194.2019.1613541. Epub 2019 May 21.

Authors

Mar Tormo¹, Estela Giménez², Marisa Calabuig¹, Alberto Talaya², Blanca Navarro¹, Paula Amat¹, Iván Martín¹, Eliseo Albert², Carlos Solano^{1

3}, David Navarro^{1

4}

Affiliations

¹ Hematology Service, Hospital Clínico Universitario, INCLIVA Health Research Institute, Valencia, Spain.
² Microbiology Service, Hospital Clínico Universitario, INCLIVA Health Research Institute, Valencia, Spain.
³ Department of Medicine, School of Medicine, University of Valencia, Valencia, Spain.
⁴ Department of Microbiology, School of Medicine, University of Valencia, Valencia, Spain.

PMID: 31111760
DOI: 10.1080/10428194.2019.1613541

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects*
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
Cytomegalovirus / genetics*
Cytomegalovirus Infections / diagnosis*
Cytomegalovirus Infections / etiology*
DNA, Viral*
Female
Humans
Leukemia, Myeloid, Acute / complications*
Leukemia, Myeloid, Acute / drug therapy
Male
Polymerase Chain Reaction
Viral Load
Viremia*

Substances

DNA, Viral